SCNI:NASDAQ
Scinai Immunotherapeutics Ltd - ADR
$0.75
arrow_downward
-0.32%(-0.0024) 1D
$0.72
arrow_downward
-3.57% (-0.027)bedtimeAfter hours
Closed: Oct 19, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SCNI...
Open
$0.75
High
$0.75
Low
$0.66
Mkt. cap
428.88K
Avg. vol.
4.43M
Volume
110.90K
52-wk high
$15.50
52-wk low
$0.66
EPS
-$2.80
Beta
2.13
Shares outstanding
706.59K
No. of employees
45
Open
$0.75
High
$0.75
Low
$0.66
Mkt. cap
428.88K
Avg. vol.
4.43M
Volume
110.90K
52-wk high
$15.50
52-wk low
$0.66
EPS
-$2.80
Beta
2.13
Shares outstanding
706.59K
No. of employees
45
News stories
From web sources and news partners
Action Forex
·
30 minutes ago
The S&P 500 Is on a Dangerous Path
Crypto Briefing
·
4 hours ago
AI stocks now make up 49% of the S&P 500, the second-highest concentration on record
Investing.com
·
5 hours ago
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.07%
TradingView
·
5 hours ago
There is no fundamental reason for stocks’ reversal, says SA analyst
Profile
BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases.
In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis. Wikipedia
About Scinai Immunotherapeutics Ltd - ADR